Unibest

Pharmaceutical intermediates

Lurasidone (Intermediates ONLY) Intermediates

3 pharmaceutical intermediates for Lurasidone (Intermediates ONLY). Indication: Major depressive disorder; Schizophrenia; Mania.

提交项目All intermediates

About Lurasidone (Intermediates ONLY)

Originator
Dainippon Sumitomo Pharma Co., Ltd
Indication
Major depressive disorder; Schizophrenia; Mania
Approved Date
10/28/2010
DS/DP
05/26/2026

Available intermediates

3 intermediates currently listed for Lurasidone (Intermediates ONLY). Request specifications, documentation or a quotation for any item below.

Lurasidone (Intermediates ONLY) intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione14805-29-9//
(1R,2R)-1,2-Cyclohexanedimethanol65376-05-8//
(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane186204-35-3//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Lurasidone (Intermediates ONLY)?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →